EPZM - Epizyme, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
23,491
21,700
10,000
8,007
2,560
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
2,560
Operating Expenses
Research Development
116,668
105,833
109,661
91,461
111,209
Selling General and Administrative
51,382
43,972
37,181
28,372
23,900
Total Operating Expenses
168,050
149,805
146,842
119,833
135,109
Operating Income or Loss
-144,559
-128,105
-136,842
-111,826
-132,549
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-51
-25
32
83
173
Income Before Tax
-138,184
-123,573
-134,645
-110,212
-132,376
Income Tax Expense
-
57
-336
0
-
Income from Continuing Operations
-138,241
-123,630
-134,309
-110,212
-132,376
Net Income
-138,241
-123,630
-134,309
-110,212
-132,376
Net Income available to common shareholders
-141,181
-123,630
-134,309
-110,212
-132,376
Reported EPS
Basic
-
-1.72
-2.18
-1.93
-3.32
Diluted
-
-1.72
-2.18
-1.93
-3.32
Weighted average shares outstanding
Basic
-
71,864
61,471
57,126
39,839
Diluted
-
71,864
61,471
57,126
39,839
EBITDA
-
-127,053
-135,203
-110,237
-132,549